0001209191-23-001354.txt : 20230104
0001209191-23-001354.hdr.sgml : 20230104
20230104183500
ACCESSION NUMBER: 0001209191-23-001354
CONFORMED SUBMISSION TYPE: 4/A
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20221208
FILED AS OF DATE: 20230104
DATE AS OF CHANGE: 20230104
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Chung Christine
CENTRAL INDEX KEY: 0001775295
FILING VALUES:
FORM TYPE: 4/A
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36740
FILM NUMBER: 23508897
MAIL ADDRESS:
STREET 1: C/O FIBROGEN, INC.
STREET 2: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: FIBROGEN INC
CENTRAL INDEX KEY: 0000921299
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
BUSINESS PHONE: 415-978-1200
MAIL ADDRESS:
STREET 1: 409 ILLINOIS STREET
CITY: SAN FRANCISCO
STATE: CA
ZIP: 94158
4/A
1
doc4a.xml
FORM 4/A SUBMISSION
X0306
4/A
2022-12-08
2022-12-09
0
0000921299
FIBROGEN INC
FGEN
0001775295
Chung Christine
C/O FIBROGEN, INC.
409 ILLINOIS ST.
SAN FRANCISCO
CA
94158
0
1
0
0
SVP, China Operations
Common Stock
2022-12-08
4
S
0
2595
15.79
D
234873
D
Represents the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units previously reported in Table I.
This Form 4/A is being filed to correct the number of shares sold by the reporting person to cover the tax obligation realized upon the vesting of restricted stock units.
/s/ Cecelia Monoarfa-Taime, Attorney-in-fact
2023-01-04